CAMK2G and catecholaminergic polymorphic ventricular tachycardia: Moreover, CaMKII inhibition prevents ventricular arrhythmias in mouse models of CPVT, and induced pluripotent stem cell-derived cardiomyocytes of CPVT patients [50].